Preview Mode Links will not work in preview mode

GRACEcast


Apr 27, 2013

David Spigel, Sarah Cannon Cancer Center, reviews how he discusses the potential advantages and disadvantages waiting on molecular marker results and sometimes seeking additional tissue in patients with advanced NSCLC.